These findings suggest that pinostilbene has no significant effect on the growth of AR-independent non-cancer cells, while it has higher cytotoxicity in AR-dependent prostate cancer cell lines where it inhibits their growth, indicating that pinostilbene specifically affects the AR signaling pathway. Here, AR is linked to prostate carcinoma.